L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 29,363 shares at $15.51 ($455K) on 2019-03-18, disclosed to the SEC on 2019-03-19.
Open-market sale of $455k RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.45 | 2,881 | $45K | 9.8% |
| 2 | $15.45 | 3,256 | $50K | 11.1% |
| 3 | $15.51 | 11,613 | $180K | 39.6% |
| 4 | $15.51 | 11,613 | $180K | 39.6% |
| Total | $15.50 avg | 29,363 | $455K | 100% |
| Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |
| RVNC | SELL | 2017-10-20 | $401K | — | Filing → |